Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma. [electronic resource]
Producer: 20160706Description: 203-17 p. digitalISSN:- 1476-5829
- Analysis of Variance
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Bone Resorption -- drug therapy
- Cat Diseases -- drug therapy
- Cats
- Cell Line, Tumor
- Cyclooxygenase 1
- Cyclooxygenase 2
- Cyclooxygenase Inhibitors -- therapeutic use
- Diphosphonates -- therapeutic use
- Disease Models, Animal
- Heterografts
- Humans
- Imidazoles -- therapeutic use
- Male
- Meloxicam
- Mice
- Mice, Nude
- Mouth Neoplasms -- drug therapy
- Neoplasms, Squamous Cell -- drug therapy
- RNA, Messenger
- Random Allocation
- Real-Time Polymerase Chain Reaction
- Thiazines -- therapeutic use
- Thiazoles -- therapeutic use
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.